Reig Jofre | Tenvalue

Reig Jofre accelerates its biopharmaceutical transformation, which began in 2018 with the integration of Leanbio

by admin | 7, Apr 2026 | Cotizadas, Reig Jofre

Reig Jofre is driving a strategic transformation from a traditional pharmaceutical company to a biopharmaceutical company, supported by the integration of Leanbio and Syna Therapeutics. This process began in 2018 with the acquisition of a stake in Leanbio and the...

REIG JOFRE acquires Leanbio and strengthens its vertical integration in biotechnology

by admin | 2, Dec 2025 | Cotizadas, Reig Jofre

Reig Jofre has consolidated its stake in Leanbio by increasing its shareholding from 47% to 85%, following the acquisition of shares valued at €3.5 million. The remaining 15% remains in the hands of the founding team and specialised shareholders. This transaction is...

Reig Jofre is considering taking control of the Catalan company Leanbio in its effort to vertically integrate into the production of biotechnology products

by admin | 9, Apr 2025 | Cotizadas, Reig Jofre

The company currently holds a 24% stake in Leanbio and has expressed its willingness to acquire a majority stake to consolidate it within Reig Jofre’s scope of operations.

Reig Jofre accelerates its biopharmaceutical transformation, which began in 2018 with the integration of Leanbio

REIG JOFRE acquires Leanbio and strengthens its vertical integration in biotechnology

Reig Jofre is considering taking control of the Catalan company Leanbio in its effort to vertically integrate into the production of biotechnology products

Recent articles